Published in

American Association for the Advancement of Science, Science Translational Medicine, 470(10), 2018

DOI: 10.1126/scitranslmed.aau5516

Links

Tools

Export citation

Search in Google Scholar

Noncoding regions are the main source of targetable tumor-specific antigens

Journal article published in 2018 by Céline M. Laumont ORCID, Krystel Vincent ORCID, Leslie Hesnard ORCID, Éric Audemard ORCID, Éric Bonneil ORCID, Jean-Philippe Laverdure ORCID, Patrick Gendron ORCID, Mathieu Courcelles ORCID, Marie-Pierre Hardy, Caroline Côté ORCID, Chantal Durette, Charles St-Pierre, Mohamed Benhammadi ORCID, Joël Lanoix, Suzanne Vobecky ORCID and other authors.
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Upload
Green circle
Postprint: archiving allowed
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

A proteogenomic method identifies potentially actionable tumor-specific antigens and shows that most of them are not coded by classic exons.